Journal article

Effect of lifelong carnitine supplementation on plasma and tissue carnitine status, hepatic lipid metabolism and stress signalling pathways and skeletal muscle transcriptome in mice at advanced age


Authors listCheema, UB; Most, E; Eder, K; Ringseis, R

Publication year2019

Pages1323-1333

JournalBritish Journal of Nutrition

Volume number121

Issue number12

ISSN0007-1145

Open access statusHybrid

DOI Linkhttps://doi.org/10.1017/S0007114519000709

PublisherCambridge University Press


Abstract
While strong evidence from clinical studies suggests benefial effects of carnitine supplementation on metabolic health, serious safety concerns associated with carnitine supplementation have been raised from studies in mice. Considering that the carnitine doses in these mice studies were up to 100 times higher than in clinical studies, the present study aimed to address possible safety concerns associated with longterm supplementation of a carnitine dose used in clinical trials. Two groups of NMRI mice were fed either a control or a carnitine-supplemented diet (1 g/kg diet) from weaning to 19 mo of age, and parameters of hepatic lipid metabolism and stress signalling and skeletal muscle gene expression were analyzed in the mice at 19 mo of age. Concentrations of free carnitine and acetylcarnitine in plasma and tissues were higher in the carnitine than in the control group (P < 0.05). Plasma concentrations of free carnitine and acetylcarnitine were higher in mice at adult age (10 and 15 mo) than at advanced age (19 mo) (P < 0.05). Hepatic mRNA and protein levels of genes involved in lipid metabolism and stress signalling and hepatic and plasma lipid concentrations did not differ between the carnitine and the control group. Skeletal muscle transcriptome analysis in 19 mo-old mice revealed only a moderate regulation between carnitine and control group. Lifelong carnitine supplementation prevents an age-dependent impairment of plasma carnitine status, but safety concerns associated with longterm supplementation of carnitine at doses used in clinical trials can be considered as unfounded.



Citation Styles

Harvard Citation styleCheema, U., Most, E., Eder, K. and Ringseis, R. (2019) Effect of lifelong carnitine supplementation on plasma and tissue carnitine status, hepatic lipid metabolism and stress signalling pathways and skeletal muscle transcriptome in mice at advanced age, British Journal of Nutrition, 121(12), pp. 1323-1333. https://doi.org/10.1017/S0007114519000709

APA Citation styleCheema, U., Most, E., Eder, K., & Ringseis, R. (2019). Effect of lifelong carnitine supplementation on plasma and tissue carnitine status, hepatic lipid metabolism and stress signalling pathways and skeletal muscle transcriptome in mice at advanced age. British Journal of Nutrition. 121(12), 1323-1333. https://doi.org/10.1017/S0007114519000709


Last updated on 2025-10-06 at 11:03